Quantitative HBsAg and its Role in Chronic Hepatitis B Patient Management
Description: Dr Gish explains how HBsAg Quantitative test can be used to phase disease and manage treatment of Hep B positive patients, discusses the testing for both HBsAg Quantitative and HBV DNA, and describes how HBsAg Quant is being used in clinical trials for new Hepatitis B drugs.
At the conclusion of this program, participants will be able to:
• Explain how Hepatitis B surface antigen (HBsAg) test can be used to determine the HBV disease phase and manage treatment of Hep B-positive patients
• Discuss why and how testing for both HBsAg Quantitative and HBV DNA help predict clinical outcomes of chronic hepatitis B patients
• Describe how HBsAg Quantitative is being used in clinical trials for new hepatitis B drugs
ASCLS P.A.C.E.® credits are available to laboratory professionals through October 4, 2017.